Dear %%First_Name_%%,  
  ACT NOW TO AVOID DISRUPTION OF SUBSCRIPTION SERVICE  
  Without your personal request to receive Pharmaceutical Technology your subscription could be interrupted temporarily or permanently! To avoid further notifications or disruption of subscription service, please click on the link below. Youll continue receiving issues at no cost, and renewing is simple and just takes a few minutes.

Click here to renew now!

Pharmaceutical Technology is geared toward professionals like you, and we welcome new subscribers in your field. Pass this message along to coworkers who would also benefit from a free subscription.

Keep your issues arriving on time. Renew today!

Michelle Hoffman
Editior-in-Chief

PS: Renew immediately to ensure delivery of your next issue. Pharmaceutical Technology continues to provide top quality industry information reviewed by prominent industry professionals on the Editorial Advisory Board, such as Roger L. Williams, MD, EVP and CEO of United States Pharmacopeia, Jim Miller, President of PharmSource Information Services Bio/Pharmaceutical Outsourcing Report, and Moheb Nasr, Director of the Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, at FDA.

  
     
  This email was sent from PharmaceuticalTechnology@replycentral.com.
Please add this email address to your address book or email whitelist to ensure you do not miss any emails from us.

  
  Pharmaceutical Technology
Advanstar
131 West First Street
Duluth, MN 55802-2065

Please follow this link if you no longer wish to receive future email communications from Pharmaceutical Technology.
http://www.dontemailme.com/OO.aspx?29696;D3899D820A7F91A0
 		 
 
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.